On September 15, according to Senate aides and lobbyists familiar with the negotiations, US Senate negotiators are crafting an artificial intelligence regulatory bill. The proposed legislation would require AI companies to demonstrate that they have taken reasonable precautions to prevent their tools from causing harm. Senators are discussing whether to authorize the US Secretary of Commerce to require AI development companies to fulfill a 'duty of care,' meaning they must prove they have taken reasonable measures to prevent harm. Additionally, the Secretary of Commerce may have the authority to send government inspectors to test corporate products. Currently, there is no consensus on what measures constitute 'reasonable.' The bill is still under discussion, and even if it passes Congress, there remains uncertainty about whether it will ultimately become law.
